Structural requirements of acetylcholinesterase reactivators
Jazyk angličtina Země Nizozemsko Médium print
Typ dokumentu časopisecké články, práce podpořená grantem, přehledy
- MeSH
- acetylcholin farmakologie MeSH
- acetylcholinesterasa metabolismus MeSH
- aktivace enzymů účinky léků MeSH
- antagonisté muskarinových receptorů farmakologie MeSH
- antidota farmakologie MeSH
- atropin farmakologie MeSH
- chemické bojové látky toxicita MeSH
- cholinesterasové inhibitory toxicita MeSH
- fosforylace MeSH
- lidé MeSH
- neurotransmiterové látky farmakologie MeSH
- nikotin farmakologie MeSH
- oximy chemie metabolismus farmakologie MeSH
- reaktivátory cholinesterázy chemie metabolismus MeSH
- receptor muskarinový M1 metabolismus MeSH
- vazebná místa MeSH
- zvířata MeSH
- Check Tag
- lidé MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- přehledy MeSH
- Názvy látek
- acetylcholin MeSH
- acetylcholinesterasa MeSH
- antagonisté muskarinových receptorů MeSH
- antidota MeSH
- atropin MeSH
- chemické bojové látky MeSH
- cholinesterasové inhibitory MeSH
- neurotransmiterové látky MeSH
- nikotin MeSH
- oximy MeSH
- reaktivátory cholinesterázy MeSH
- receptor muskarinový M1 MeSH
Nerve agents (sarin, soman, cyclosarin, tabun and VX agent) and pesticides (paraoxon, chlorpyrifos, TEPP) represent extremely toxic group of organophosphorus compounds (OPCs). These compounds inhibit enzyme acetylcholinesterase (AChE, EC 3.1.1.7) via its phosphorylation or phosphonylation at the serine hydroxy group in its active site. Afterwards, AChE is not able to serve its physiological function and intoxicated organism is died due to overstimulation of cholinergic nervous system. The current standard treatment of poisoning with highly toxic OPCs usually consists of the combined administration of anticholinergic drugs (preferably atropine) and AChE reactivators (called "oximes"). Anticholinergic drugs block effects of accumulated neurotransmitter acetylcholine at nicotinic and muscarinic receptor sites, while oximes reactivate AChE inhibited by OPCs. Unfortunately, none from the currently used oximes is sufficiently effective against all known nerve agents and pesticides. Therefore, to find new oximes able to sufficiently reactivate inhibited AChE (regardless of the type of OPCs) is still very important task for medicinal chemistry with the aim to improve the efficacy of antidotal treatment of the acute poisonings mentioned. In this paper, the relationship between chemical structure of AChE reactivators and their ability to reactivate AChE inhibited by several nerve agents and pesticides is summarized. It is shown that there are several structural fragments possibly involving in the structure of proposed AChE reactivators. Finally, an attempt of a future course of new AChE reactivators development is discussed.
Citace poskytuje Crossref.org
Strategies for enhanced bioavailability of oxime reactivators in the central nervous system
Trends in the Recent Patent Literature on Cholinesterase Reactivators (2016-2019)
Acetylcholinesterase: The "Hub" for Neurodegenerative Diseases and Chemical Weapons Convention
Novel Group of AChE Reactivators-Synthesis, In Vitro Reactivation and Molecular Docking Study
Amperometric Biosensors for Real Time Assays of Organophosphates
Two step synthesis of a non-symmetric acetylcholinesterase reactivator